Latest:
Approximately Half of Patients Demonstrated Poor Health Literacy Prior to Biosimilar Switch
© 2024 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
Latest:
Approximately Half of Patients Demonstrated Poor Health Literacy Prior to Biosimilar Switch
Latest:
Contributor: What Is the Value of the Interchangeability Designation for a Biosimilar?
Latest:
Breaking Down Biosimilar Barriers: Interchangeability
Latest:
Contributor: The Biosimilars Wave Is Crashing on the Shores of Biopharma Development
Latest:
Contributor: Self-Administered Biosimilars Are Coming Quickly—Is Your Clinic Ready?
Latest:
Dr Ryan Haumschild Draws Link Between Biosimilars, Health Equity in Breast Cancer